Cary Street Partners Investment Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
Cary Street Partners Investment Advisory's CL Position: Q2 2026 in Review
Cary Street Partners Investment Advisory increased its Colgate-Palmolive (CL) stake by 56% in Q2 2026, buying an estimated $58K and bringing the position to 1,851 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #408.
Cary Street Partners Investment Advisory first reported a position in CL in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.63M in Q3 2020. 976 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Cary Street Partners Investment Advisory held 1,851 shares of Colgate-Palmolive worth $170K as of Q2 2026.
- Cary Street Partners Investment Advisory bought 663 Colgate-Palmolive shares in Q2 2026, an estimated $58K.
- Colgate-Palmolive made up 0.03% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #408 holding.
- Cary Street Partners Investment Advisory first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 22 quarters since.
- Cary Street Partners Investment Advisory's Colgate-Palmolive position peaked at $2.63M in Q3 2020.
- 976 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.